- Home
- HTD vs IART Comparison
HTD vs IART Comparison
Compare HTD & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTD
- IART
- Stock Information
- Founded
- HTD 2004
- IART 1989
- Country
- HTD United States
- IART United States
- Employees
- HTD N/A
- IART N/A
- Industry
- HTD Finance Companies
- IART Medical/Dental Instruments
- Sector
- HTD Finance
- IART Health Care
- Exchange
- HTD Nasdaq
- IART Nasdaq
- Market Cap
- HTD 850.4M
- IART 978.4M
- IPO Year
- HTD N/A
- IART 1995
- Fundamental
- Price
- HTD $24.02
- IART $12.80
- Analyst Decision
- HTD
- IART Hold
- Analyst Count
- HTD 0
- IART 9
- Target Price
- HTD N/A
- IART $19.43
- AVG Volume (30 Days)
- HTD 92.3K
- IART 1.1M
- Earning Date
- HTD 01-01-0001
- IART 07-31-2025
- Dividend Yield
- HTD 8.59%
- IART N/A
- EPS Growth
- HTD N/A
- IART N/A
- EPS
- HTD N/A
- IART N/A
- Revenue
- HTD N/A
- IART $1,624,308,000.00
- Revenue This Year
- HTD N/A
- IART $5.56
- Revenue Next Year
- HTD N/A
- IART $4.41
- P/E Ratio
- HTD N/A
- IART N/A
- Revenue Growth
- HTD N/A
- IART 6.19
- 52 Week Low
- HTD $16.17
- IART $11.06
- 52 Week High
- HTD $22.13
- IART $32.49
- Technical
- Relative Strength Index (RSI)
- HTD 58.25
- IART 53.15
- Support Level
- HTD $23.71
- IART $11.08
- Resistance Level
- HTD $24.30
- IART $13.69
- Average True Range (ATR)
- HTD 0.25
- IART 0.65
- MACD
- HTD -0.01
- IART 0.01
- Stochastic Oscillator
- HTD 53.52
- IART 62.77
About HTD John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest
John Hancock Tax-advantaged Div Inc Fd is a closed-end, diversified management investment company. Its investment objective is to provide a high after-tax total return from dividend income and capital appreciation. The fund's portfolio composition consists of common stocks, preferred securities, corporate bonds, convertible bonds, and short-term investments. Its sector composition comprises utilities, financials, energy, telecommunication services, industrials, healthcare, real estate, consumer discretionary and short-term investments.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.